The Comparator Tool builds from the PharmaVitae profiles of the 50 leading pharma companies. Updated monthly, the tool allows you to compare the 50 players by current and forecast sales to 2012.
Key reasons to purchase this title
- Compare players by US or global forecast therapy area sales and portfolio breakdown measures to identify winners and losers over the next seven years
- Drill down to the individual drug forecast level for each company, identifying the key drivers behind forecast performance over the next seven years
- Access over 150,000 continuously tracked data points analyzing current and future trends in the pharmaceutical and biotech arenas
